Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia.
Philippot Q, Fekkar A, Gervais A, Le Voyer T, Boers LS, Conil C, Bizien L, de Brabander J, Duitman JW, Romano A, Rosain J, Blaize M, Migaud M, Jeljeli M, Hammadi B, Desmons A, Marchal A; ArtDECO consortium; COVID HGE consortium; Mayaux J, Zhang Q, Jouanguy E, Borie R, Crestani B, Luyt CE, Adle-Biassette H, Sene D, Megarbane B, Cobat A, Bastard P, Bos LDJ, Casanova JL, Puel A.
Philippot Q, et al. Among authors: duitman jw.
J Clin Immunol. 2023 Aug;43(6):1093-1103. doi: 10.1007/s10875-023-01512-9. Epub 2023 May 20.
J Clin Immunol. 2023.
PMID: 37209324
Free PMC article.